▲ Peaking
Business
🔮 holds ✗
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2026
Eli Lilly shares surge following CHMP's recommendation for Jaypirca's EU approval and expanded Medicare access for GLP-1 drugs.